.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Amedra Pharms Company Profile

« Back to Dashboard

Summary for Applicant: Amedra Pharms

Patents:2
Tradenames:7
Ingredients:5
NDAs:6
Drug Master File Entries: 0
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amedra Pharms
TWINJECT 0.15
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020800-002May 28, 2004DISCNNo7,621,891<disabled>Y <disabled>
Amedra Pharms
DEXEDRINE
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL017078-003Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Amedra Pharms Llc
ALBENZA
albendazole
TABLET;ORAL020666-001Jun 11, 1996RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc